IMCLONE SYSTEMS INC/DE
S-3/A, EX-23.1, 2000-07-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: IMCLONE SYSTEMS INC/DE, S-3/A, EX-5.1, 2000-07-12
Next: IMCLONE SYSTEMS INC/DE, S-3/A, EX-23.3, 2000-07-12





                                                                   Exhibit 23.1



                              ACCOUNTANTS' CONSENT






The Board of Directors
ImClone Systems Incorporated:

We consent to the use of our report incorporated herein by reference and to the
reference to our firm under the heading "Experts" in the prospectus.


                                                                /s/ KPMG LLP

Princeton, New Jersey
July 12, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission